Literature DB >> 3923114

An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.

T Kiyohara, J W Dennis, R J Boegman, J C Roder.   

Abstract

Glycosidic enzymes were used as probes to analyze the mechanism of NK cell-mediated cytotoxicity. Pretreatment of nylon wool-enriched CBA/J spleen cells, a murine NK clone, or human peripheral blood lymphocytes (PBL) with alpha-mannosidase, an exoglycosidase, led to a marked dose-dependent inhibition of NK lytic activity against YAC-1.2 or K562 tumor cells. Maximal inhibition occurred after a 60-min pretreatment of murine effectors at 37 degrees C, and the kinetics of NK inhibition by alpha-mannosidase was similar to the reported kinetics for enzymatic activity. Released hexose was detected chemically in the supernatant of mouse spleen cells treated with NK inhibitory dose of alpha-mannosidase, and inactivation of enzymatic function with EDTA reversed the NK inhibitory effect. These results suggest that alpha-mannosidase inhibited NK function by virtue of its enzymatic action. Culture of human PBL for 20-hr after treatment with this enzyme led to a greater than 70% recovery in NK lytic function. Recovery was blocked by incorporating tunicamycin, a glycosylation inhibitor of asparagine-linked glycoproteins, into the culture medium. These results suggest that the alpha-mannosidase-sensitive site may be de novo synthesized glycoprotein. Neuraminidase, beta-galactosidase, endo-beta-N-acetylglucosaminidase-D and H, and peptide-N-glycosidase treatments did not inhibit human NK cell lysis of K562 cells. Pretreatment of nylon wool-enriched CBA/J spleen cells or Percoll-enriched human LGL with alpha-mannosidase did not influence their capacity to bind YAC 1.2 target cells or K562 target cells, respectively, Ca++ pulse experiments revealed that the alpha-mannosidase-sensitive site on the NK cells was involved after target-effector binding but before the Ca++ influx. Pretreatment of effector cells with this enzyme which normally occurs after effector-target cell interaction. These results suggest that the phospholipid methylation reaction is coupled to the alpha-mannosidase-sensitive site on the NK cells. By analogy to other physiologic systems, such as histamine release in mast cells, the triggering of phospholipid methylation in the NK cells may serve as a mechanism for signal transduction across the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923114

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.

Authors:  G C Starling; S E Davidson; J L McKenzie; D N Hart
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

2.  Immunomodulatory effects of pulmonary surfactant on natural killer cell and antibody-dependent cytotoxicity.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

3.  BCG induced killer cell activity.

Authors:  S Koga; T Kiyohara; K Taniguchi; M Nishikido; S Kubota; T Sakuragi; K Shindo; Y Saitoh
Journal:  Urol Res       Date:  1988

4.  Peripheral membrane molecules of leukocytes and NK cytotoxicity.

Authors:  J Kubrycht; P Malíková; N H Huan; A Fiserová; K Bezouska; P Kruzík; K Stajner; V Moravec; M Pospísil
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

5.  Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans.

Authors:  M R Hidore; J W Murphy
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Induction of lymphokine-activated killer-like cells by cancer chemotherapy.

Authors:  T Kiyohara; K Taniguchi; S Kubota; S Koga; T Sakuragi; Y Saitoh
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

7.  Inhibition of N-linked oligosaccharide trimming mannosidases blocks human B cell development.

Authors:  A Tulp; M Barnhoorn; E Bause; H Ploegh
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.